Related Experiment Videos
Apolipoprotein and lipid abnormalities in chronic liver failure
A C Spósito1, C G Vinagre, F L Pandullo
1Instituto do Coração, Faculdade de Medicina, Universidade de São Paulo, Brasil.
Summary
Patients with chronic liver failure show a greater decrease in HDL cholesterol than apolipoprotein A-I. The HDL cholesterol to apolipoprotein A-I ratio serves as a marker for liver function in these patients.
Area of Science:
- Biochemistry
- Hepatology
- Clinical Chemistry
Background:
- Chronic liver failure significantly alters lipid metabolism.
- Lipoprotein and apolipoprotein levels are often dysregulated in liver disease.
Purpose of the Study:
- To investigate serum lipid and apolipoprotein levels in patients with chronic liver failure.
- To evaluate the ratio of HDL cholesterol to apolipoprotein A-I as a potential marker of liver function.
Main Methods:
- Quantification of total serum lipids, apolipoproteins A-I and B.
- Analysis of VLDL, LDL, and HDL lipid fractions.
- Correlation analysis of HDLc:apo A-I ratio with plasma albumin and Child classification.
Main Results:
- Reduced VLDL, LDL, HDL, apo A-I, and apo B in liver failure patients.
- More pronounced reduction in HDL cholesterol compared to apo A-I.
- Significantly lower HDLc:apo A-I ratio in liver failure patients.
- HDLc:apo A-I ratio correlated with liver function (Child classification).
Conclusions:
- The HDLc:apo A-I ratio is a sensitive indicator of liver function in chronic liver failure.
- Decreased lecithin-cholesterol acyltransferase production may contribute to the observed ratio changes.
- This ratio may aid in assessing disease severity and progression.